From the Department of Cardiology, Hospital General Universitario
Gregorio Marañón, Universidad Complutense de Madrid, Spain.
Correspondence to Javier Botas, MD, Laboratorio de Hemodinámica, Departamento de Cardiología, Hospital General Universitario Gregorio Marañón, Dr Esquerdo 46, 28007 Madrid, Spain. E-mail javbotas{at}jet.es
Methods and ResultsFifty-seven lesions from 50 patients treated
with high-pressure (median±interquartile range, 14±2 atm) elective
(44 de novo, 13 restenotic lesions) stenting were prospectively
studied (29 Wiktor, Medtronic; 28 Palmaz-Schatz, Cordis Corp). Balloon
subexpansion was calculated as the difference between maximal and
minimal balloon cross-sectional areas at peak pressure measured by
automatic edge detection; elastic recoil was calculated as the
difference between minimal measured balloon size and IVUS-derived
minimal lumen area within the stent. Angiographic residual diameter
stenosis was 10±13% (reference diameter, 3.1±0.7 mm;
balloon to artery ratio, 1.12±0.23) and IVUS-derived stent expansion
was 80±28%. However, although balloon nominal size was 9.6±1.3
mm2 and maximal balloon size measured inside the
coronary lumen was 12.5±3.2 mm2, final stent
minimal lumen area was only 7.1±2.2 mm2. Balloon
subexpansion of 4.0±1.8 mm2 (33%) and elastic recoil
of 1.6±2.3 mm2 (20%) (both P<0.0001)
were the two mechanisms responsible for residual luminal
stenosis. Wiktor stent and peak inflation pressure correlated
with balloon subexpansion, whereas Wiktor stent, de novo lesion, and
minimal lumen area at baseline correlated with elastic recoil.
ConclusionsDespite high-pressure deployment, lumen dimensions
after stenting are only 57% of maximal achievable. Inadequate balloon
expansion and elastic recoil are responsible for residual lumen
stenosis, suggesting that plaque characteristics and stent
resistance deserve further investigation.
Written informed consent for intracoronary stenting and IVUS
examination was obtained from all patients.
Procedure
Coronary angiography was performed through the femoral
approach (8F catheters). Several angiographic projections of the
segment of interest were obtained before intervention. The target
lesion was predilated and stented by use of standard techniques.
Balloon catheters (noncompliant and semicompliant) were selected among
several manufacturers and sized according to angiographic vessel size.
Balloons shorter than 20 mm were not used. Selection of type,
length, and size of the stent was left to the individual operator, and
the maximal inflation pressure (
Quantitative Coronary Angiography
Interobserver and intraobserver (>3 months apart) variabilities
(10 randomly selected angiograms) of minimal balloon diameters were
±0.19 mm (±6%) and ±0.17 mm (±4%), corresponding to
±0.9 mm2 (±13%) and ±1.1
mm2 (±9%) of balloon minimal CSA, respectively.
Rintraclass values of interobserver and
intraobserver reproducibilities were 0.72 and 0.95, respectively.
Intravascular Ultrasound
In 35 lesions (19 Wiktor, 16 Palmaz-Schatz), IVUS examination was
also performed at baseline. From the image showing the smallest lumen,
the following morphometric variables were
measured13: MLA, plaque area, plaque
eccentricity, arc of calcium (none, <90°, or >90°), and
normalized plaque echogenicity (ratio between gray-scale values of
plaque and adventitia).
Derived Parameters
Statistical Analysis
IVUS and QCA Assessment of Final MLA
Balloon nominal CSA was 9.6±1.3 mm2
(Wiktor, 9.6±1.4; Palmaz-Schatz, 9.6±2.2
mm2; P=0.8), and maximal balloon
dimension measured inside the coronary lumen was 12.5±3.2
mm2 (Wiktor, 13.0±3.5; Palmaz-Schatz,
11.4±3.1 mm2; P=0.08); however,
final stent MLA was only 7.1±2.2 mm2, 74%
and 57% of these values, respectively. At the end of the procedure,
only 55% (6.1±3.0 mm2) of maximal
achievable acute luminal gain (11.0±3.5
mm2) was obtained (P<0.0001; Figure 1
Balloon Subexpansion
Elastic Recoil
Factors Related to Balloon Subexpansion and Elastic Recoil
Balloon-Vessel Interaction During Stent Deployment
An interference of stent architecture with balloon expansion
constitutes another potential source of subexpansion. However, it has
been reported that Palmaz-Schatz stents expand by almost 90% of peak
size below 5 atm.25 Beyond this point, it is
believed that no significant increase in pressure is needed in vitro to
achieve full expansion of the balloon-stent assembly compared with the
balloon alone. Because strain hardening of 316L stainless steel during
stent expansion is negligible (Cordis Corp, unpublished data, 1997),
stent size should parallel the size of the balloon without imposing
relevant resistance. Whether stents behave similarly during in vivo
high-pressure implantation remains to be ascertained.
Greater balloon subexpansion was observed for Wiktor than for
Palmaz-Schatz stents in the present study. However, because maximal
achieved balloon size was also larger for Wiktor stents, we believe
such a difference in subexpansion could be due in part to greater
compliance of the balloons used for Wiktor stent deployment. This
hypothesis is supported by the observation of similar values of
relative balloon subexpansion in both stent types, a
parameter that corrects for differences in maximal balloon
size within the coronary lumen.
Elastic Recoil During Stent Implantation
Due to their low yield point (close to 0.1 atm),
balloon-expandable stents are plastically deformed during deployment
and compression.35 36 However, greater force is
needed in vivo to compress than to expand the stent due to the
favorable effects of vessel impaction, friction, and longitudinal
constraint.37 Pressures >0.8 and 0.5 atm are
necessary to focally compress Wiktor and Palmaz-Schatz stents,
respectively, in vitro.38 39 The observation of
1.6 mm2 (20%) of lumen recoil therefore
demonstrates that elastic vessel hoop stress is above these values.
Differences in vessel compliance probably account for the greater
recoil observed in de novo than in restenotic lesions.
Nevertheless, plaque protrusion through the stent struts also needs to
be considered as a mechanism of lumen recoil, as demonstrated by
IVUS40 and angioscopy
examinations.41 Due to their smaller metallic
surface, this mechanism may be responsible for the greater vessel
recoil observed in coil stents in the present and in previous
studies.42
Study Limitations
Lesions were predilated before stenting to allow the introduction
of the device; it cannot be excluded that some noncontrolled factors,
such as balloon type, size, or inflation pressure, might have
influenced balloon subexpansion or elastic recoil.
Because baseline IVUS data were unavailable in a subset of
patients, this study cannot correctly address how important plaque
characteristics are as determinants of subexpansion and recoil;
however, in the subset of lesions available, these factors seem less
important than other procedural variables.
Clinical Implications
Received December 3, 1997;
revision received February 27, 1998;
accepted March 1, 1998.
2.
Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute
stent thrombosis: evolving issues and current concepts. J Am
Coll Cardiol. 1996;27:494503.[Abstract]
3.
Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler
LF, Popma JJ, Wong SC, Leon MB. Small stent size and intimal
hyperplasia contribute to restenosis: a volumetric
intravascular ultrasound analysis. J Am Coll
Cardiol. 1995;26:720724.[Abstract]
4.
Kuntz RE, Safian RD, Carrozza JP, Fischman DL, Mansour
M, Baim DS. The importance of acute luminal diameter in determining
restenosis after coronary atherectomy or stenting.
Circulation. 1992;86:18271835.
5.
Ikari Y, Hara K, Tamura T, Saeki F, Yamaguchi T.
Luminal loss and site of restenosis after Palmaz-Schatz
coronary stent implantation. Am J Cardiol. 1995;76:117120.[Medline]
[Order article via Infotrieve]
6.
Görge G, Haude M, Ge J, Voegele E, Gerber T,
Rupprecht HJ, Meyer J, Erbel R. Intravascular ultrasound after low and
high inflation pressure coronary artery stent implantation.
J Am Coll Cardiol. 1995;26:725730.[Abstract]
7.
Nakamura S, Hall P, Gaglione A, Tiecco F, Di Maggio M,
Maiello L, Martini G, Colombo A. High pressure assisted
coronary stent implantation accomplished without intravascular
ultrasound guidance and subsequent anticoagulation. J Am
Coll Cardiol. 1997;29:2127.[Abstract]
8.
Moussa I, Di Mario C, Di Francesco L, Reimers B,
Blengino S, Colombo A. Subacute stent thrombosis and the
anticoagulation controversy: changes in drug therapy, operator
technique, and the impact of intravascular ultrasound. Am J
Cardiol. 1996;78:1317.[Medline]
[Order article via Infotrieve]
9.
Botas J, Elízaga J, García E, Bermejo
J, Soriano J, Abeytua M, Velasquez E, Fernández A, Delcán
JL. IVUS assessment of high pressure stent implantation. J
Am Coll Cardiol. 1996;27(suppl A):199A. Abstract.
10.
Núñez BD, Holmes DR, Lerman A, Berger PB,
Garratt KN, Higano ST. Detailed intravascular ultrasound
analysis after routine high pressure assisted
intracoronary stent implantation. J Am Coll
Cardiol. 1996;27(suppl A):199A. Abstract.
11.
Hauslelter J, Nolte CWT, Jost S, Wiese B, Sturm M,
Lichtlen PR. Comparison of different quantitative coronary
analysis systems: ARTREK, CAAS and CMS. Cathet Cardiovasc
Diagn. 1996;37:1422.[Medline]
[Order article via Infotrieve]
12.
Leung WH, Demopulos PA, Alderman AG, Sanders W, Stadius
ML. Evaluation of catheters and metallic catheter markers as
calibration standard for measurement of coronary dimension.
Cathet Cardiovasc Diagn. 1990;21:148153.[Medline]
[Order article via Infotrieve]
13.
Baptista J, di Mario C, Ozaki Y, Escaned J, Gil
R, de Feyter P, Roelandt JR, Serruys PW. Impact of plaque morphology
and composition on the mechanisms of lumen enlargement using
intracoronary ultrasound and quantitative angiography after
balloon angioplasty. Am J Cardiol. 1996;77:115121.[Medline]
[Order article via Infotrieve]
14.
Hermans WR, Rensing BJ, Strauss BH, Serruys PW.
Methodological problems related to the quantitative assessment of
stretch, elastic recoil, and balloon-artery ratio. Cathet
Cardiovasc Diagn. 1992;25:174185.[Medline]
[Order article via Infotrieve]
15.
Bland JM, Altman DG. Statistical methods for assessing
agreement between two methods of clinical measurement.
Lancet. 1986;8:307310.
16.
Tammemagi MC, Frank JW, Leblanc M, Artsob H, Streiner
DL. Methodological issues in assessing reproducibility: a comparative
study of various indices of reproducibility applied to repeat ELISA
serologic tests for Lyme disease. J Clin Epidemiol. 1995;48:11231132.[Medline]
[Order article via Infotrieve]
17.
Haude M, Erbel R, Issa H, Meyer J. Quantitative
analysis of elastic recoil after balloon angioplasty and after
intracoronary implantation of balloon-expandable Palmaz-Schatz
stents. J Am Coll Cardiol. 1993;21:2634.[Abstract]
18.
Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg
SL, Maiello L, Finci L, Tobis JM. Intracoronary ultrasound
observations during stent implantation. Circulation. 1994;89:20262034.
19.
Serruys PW, de Jaegere P, Kiemeneij F, Macaya C,
Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P,
Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J,
Morel MA. A comparison of balloon-expandable-stent implantation with
balloon angioplasty in patients with coronary artery disease.
N Engl J Med. 1994;331:489495.
20.
Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP,
Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R,
Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J,
Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldber S. A
randomized comparison of coronary-stent placement and balloon
angioplasty in the treatment of coronary artery disease: Stent
Restenosis Study Investigators. N Engl J
Med. 1994;331:496501.
21.
Hjemdahl-Monsen CE, Ambrose JA, Borrico S, Cohen M,
Sherman W, Alexopoulos D, Gorlin R, Fuster V. Angiographic patterns of
balloon inflation during percutaneous transluminal
coronary angioplasty: role of pressure-diameter curves in
studying distensibility and elasticity of the stenotic lesion
and the mechanism of dilation. J Am Coll Cardiol. 1990;16:569575.[Abstract]
22.
Chenu P, Zakhia R, Marchandise B, Jamart J, Michel X,
Schroeder E. Resistance of the atherosclerotic plaque during
coronary angioplasty: a multivariate
analysis of clinical and angiographic variables.
Cathet Cardiovasc Diagn. 1993;29:203209.[Medline]
[Order article via Infotrieve]
23.
Roubin GS, Douglas JS Jr, King SB, Lin SF,
Hutchison N, Thomas RG, Gruentzig A. Influence of balloon size on
initial success, acute complications, and restenosis after
percutaneous transluminal coronary angioplasty:
a prospective randomized study. Circulation. 1988;78:557565.
24.
Alfonso F, Goicolea J, Hernandez R, Fernandez-Ortiz A,
Segovia J, Banuelos C, Aragoncillo P, Phillips P, Macaya C.
Arterial perforation during optimization of
coronary stents using high-pressure balloon inflations.
Am J Cardiol. 1996;78:11691172.[Medline]
[Order article via Infotrieve]
25.
Palmaz JC, Kopp DT, Hayashi H, Schatz RA, Hunter G, Tio
FO, Garcia O, Alvarado R, Rees C, Thomas SC. Normal and
stenotic renal arteries: experimental balloon-expandable
intraluminal stenting. Radiology. 1987;164:705708.
26.
Rozenman Y, Gilon D, Welber S, Sapoznikov D, Gotsman
MS. Clinical and angiographic predictors of immediate recoil after
successful coronary angioplasty and relation to late
restenosis. Am J Cardiol. 1993;72:10201025.[Medline]
[Order article via Infotrieve]
27.
Rodríguez AE, Palacios IF, Fernández MA,
Larribau M, Giraudo M, Ambrose JA. Time course and mechanism of early
luminal diameter loss after percutaneous transluminal
coronary angioplasty. Am J Cardiol. 1995;76:11311134.[Medline]
[Order article via Infotrieve]
28.
Itoh A, Hall P, Maiello L, Blengino S, Ferraro M,
Martini G, Finci L, Colombo A. Acute recoil of Palmaz-Schatz stent: a
rare cause of suboptimal stent implantation: report of two cases with
intravascular ultrasound findings. Cathet Cardiovasc Diagn. 1996;37:334338.[Medline]
[Order article via Infotrieve]
29.
Maiello L, Itoh A, Colombo A. Valutazione del
"recoil" acuto dello stent di Palmaz-Schatz mediante ecografia:
descrizione di un caso. Cardiologia. 1996;41:559562.[Medline]
[Order article via Infotrieve]
30.
Serruys PW, de Jaegere P, Bertrand M, Kober G, Marquis
JF, Piessens J, Uebis R, Valeix B, Wiegand V. Morphologic change in
coronary artery stenosis with the Medtronic Wiktor
stent: initial results from the core laboratory for quantitative
angiography. Cathet Cardiovasc Diagn. 1991;24:237245.[Medline]
[Order article via Infotrieve]
31.
de Jaegere P, Serruys PW, van Es GA, Bertrand M,
Wiegand V, Marquis JF, Vrolicx M, Piessens J, Valeix B, Kober G, Rutsch
W, Uebis R. Recoil following Wiktor stent implantation for
restenotic lesions of coronary arteries. Cathet
Cardiovasc Diagn. 1994;32:147156.[Medline]
[Order article via Infotrieve]
32.
White CJ. Stent recoil: comparison of the Wiktor-GX
coil and the Palmaz-Schatz tubular coronary stent. Cathet
Cardiovasc Diagn. 1997;41:13.[Medline]
[Order article via Infotrieve]
33.
Rechavia E, Litvack F, Macko G, Eigler N. Influence of
expandable balloon diameter on Palmaz-Schatz stent recoil. Cathet
Cardiovasc Diagn. 1995;36:1116.[Medline]
[Order article via Infotrieve]
34.
Painter JA, Mintz GS, Wong SC, Popma JJ, Pichard AD,
Kent KM, Satler LF, Leon MB. Serial intravascular ultrasound studies
fail to show evidence of chronic Palmaz-Schatz stent recoil.
Am J Cardiol. 1995;75:398400.[Medline]
[Order article via Infotrieve]
35.
Berry JL, Newman VS, Ferrario CM, Routh WD, Dean RH. A
method to evaluate the elastic behavior of vascular stents. J
Vasc Interv Radiol. 1996;7:381385.[Medline]
[Order article via Infotrieve]
36.
Lossef SV, Lutz RJ, Mundorf J, Barth KH. Comparison of
mechanical deformation properties of metallic stents with use of
stress-strain analysis. J Vasc Interv Radiol. 1994;5:341349.[Medline]
[Order article via Infotrieve]
37.
Flueckiger F, Sternthal H, Klein GE, Aschauer M, Szolar
D, Kleinhappl G. Strength, elasticity and plasticity of expandable
metal stents: in vitro studies with three types of stress. J Vasc
Interv Radiol. 1994;5:745750.[Medline]
[Order article via Infotrieve]
38.
White CJ, van der Krieken T. The Wiktor stent. In:
Sigwart U, ed. Endoluminal Stenting. London, England: WB
Saunders; 1996:185189.
39.
Sklar M, Schatz RA. The Palmaz-Schatz stent. In:
Sigwart U, ed. Endoluminal Stenting. London, England: WB
Saunders; 1996:160172.
40.
Ponde CK, Aroney CN, McEniery PT, Bett JH. Plaque
prolapse between the struts of the intracoronary Palmaz-Schatz
stent: report of two cases with a novel treatment of this unusual
problem. Cathet Cardiovasc Diagn. 1997;40:353357.[Medline]
[Order article via Infotrieve]
41.
Strumpf RK, Heuser RR, Eagan JT. Angioscopy: a valuable
tool in the deployment and evaluation of intracoronary stents.
Am Heart J. 1993;126:12041210.[Medline]
[Order article via Infotrieve]
42.
Werner GS, Schünemann S, Ferrari M, Figulla HR,
Kreuzer H. Comparison of slotted-tube and coil stents after
high-pressure stent deployment by intravascular ultrasound.
J Am Coll Cardiol. 1997;27(suppl A):275A. Abstract.
43.
Reiber JH, van der Zwet PM, Koning G, von Land CD, van
Meurs B, Gerbrands JJ, Buis B, van Voorthuisen AE. Accuracy and
precision of quantitative digital coronary arteriography:
observer-, short-, and medium-term variabilities. Cathet
Cardiovasc Diagn. 1993;28:187198.[Medline]
[Order article via Infotrieve]
44.
Strauss BH, Rensing BJ, den Boer A, van der Giessen WJ,
Reiber JH, Serruys PW. Do stents interfere with the densitometric
assessment of a coronary artery lesion? Cathet Cardiovasc
Diagn. 1991;24:259264.[Medline]
[Order article via Infotrieve]
45.
Isner JM, Rosenfield K, Losordo DW, Rose L, Langevin
RE, Razvi S, Kosowsky BD. Combination balloon-ultrasound imaging
catheter for percutaneous transluminal angioplasty:
validation of imaging, analysis of recoil and identification of
plaque fracture. Circulation. 1991;84:739754.
46.
Hoffman R, Mintz GS, Dussaillant GR, Popma JJ, Pichard
AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of
in-stent restenosis: a serial intravascular ultrasound study.
Circulation. 1996;94:12471254.
47.
Stone GW, Hodgson JM, St Goar FG, Frey A, Mudra H,
Sheehan H, Linnemeier TJ. Improved procedural results of
coronary angioplasty with intravascular ultrasound-guided
balloon sizing: the CLOUT Pilot Trial. Circulation. 1997;95:20442052.
48.
Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD,
Satler LF, Wong C, Brahimi A, Bucher T, Leon MB. Safety and efficacy of
elective stent implantation following rotational atherectomy in large
calcified coronary arteries. Cathet Cardiovasc
Diagn. 1996;(suppl 3):5054.
49.
Moussa I, Di Mario C, Moses J, Reimers B, Di Francesco
L, Martini G, Tobis J, Colombo A. Coronary stenting after
rotational atherectomy in calcified and complex lesions: angiographic
and clinical follow-up results. Circulation. 1997;96:128136.
50.
Moussa I, Moses JW, Strain JE, Kreps EM, Peters MJ,
Colombo A. Angiographic and clinical outcome of patients undergoing
"Stenting After Optimal Lesion Debulking": the "SOLD" pilot
study. Circulation. 1997;96(suppl I):I-81. Abstract.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
Mechanisms of Residual Lumen Stenosis After High-Pressure Stent Implantation
A Quantitative Coronary Angiography and Intravascular Ultrasound Study
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References
BackgroundIntravascular ultrasound
(IVUS) studies have demonstrated that stents are frequently
suboptimally expanded despite the use of high pressures for deployment.
The purpose of this study was to identify the mechanisms responsible
for such residual lumen stenosis.
Key Words: stents ultrasonics revascularization angioplasty balloon
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
The final dimension
of the vessel lumen has been shown to be crucial both for reducing the
risk of subacute occlusion1 2 and for
improving long-term patency after intracoronary stent
implantation.3 4 5 IVUS has demonstrated that
despite excellent angiographic results, the stented lumen may still be
further enlarged with additional balloon inflations at high
pressures.1 6 This observation has led to the
routine use of high inflation pressures for stent deployment, although
long-term data regarding the benefit of this strategy are
sparse.7 8 Moreover, recent IVUS
studies9 10 have demonstrated that even when
routinely implanted using high pressures, stents frequently remain
suboptimally expanded. The present study was therefore designed to
elucidate the mechanisms responsible for residual lumen
stenosis after high-pressure coronary stenting.
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
Patients
From May 1994 to January 1997, patients were enrolled
prospectively if (1)
1 lesion was treated with a single elective
Wiktor or Palmaz-Schatz stent implantation not preceded by any
interventional device other than standard balloon predilation, and (2)
IVUS examination was performed to assess the results of the procedure.
Lesions with suboptimal angiographic or IVUS recordings were
rejected. Thus, 57 coronary lesions (44 de novo; 13
restenotic; 29 Wiktor and 28 Palmaz-Schatz stents) from 50
patients (mean age, 59±14 years; 48 men, 2 women) constitute the basis
of this study. At the time of intervention, 17 patients had stable
angina, 29 had unstable angina, and 4 had postinfarction angina or
inducible ischemia. The target vessel was the left anterior
descending artery in 26 lesions, the right coronary artery in
20, the left circumflex in 10, and the left main in 1.
All patients were premedicated with aspirin. Heparin was
given as a bolus at the beginning of (10 000 to 15 000 IU IV) and
during angioplasty (activated clotting time >300 seconds).
After stenting, 46 patients received aspirin (150 to 360 mg/d) and
ticlopidine (250 to 500 mg/d) and 4 received acenocoumarol.
12 atm). If a residual
stenosis persisted, additional balloon inflations were allowed,
with larger balloons used if necessary. Balloons were filled with a 1:1
salinecontrast medium solution and were filmed during every inflation
at maximum pressure. Special attention was given to purge the balloon
and to allow sufficient time to achieve complete expansion during each
inflation. Intracoronary nitroglycerin (200
µg) was administered before every set of angiograms and IVUS
pullbacks.
Paired, identical, orthogonal views before and after
stenting were chosen for QCA with the use of the Coronary
Measurement System (versions 2.1 and 3.0, MEDIS Medical Imaging
Systems).11 End-diastolic frames were
selected for analysis, and the contrast-filled guiding
catheters were used as the scaling device. A single catheter of each
model used in the study was measured ex vivo filled with contrast on a
1-cm grid.12 Calibration factors were derived
from these measurements for each catheter model and then used for in
vivo analyses. MLDs and reference lumen diameters at baseline
and after stenting were measured, as well as minimal, mean, and maximal
balloon diameters at peak pressure. All balloon measurements were taken
within balloon shoulders, and minimal balloon diameter was measured
within stent boundaries. Diameters were averaged from paired angiograms
when available; a circular shape was assumed when areas were
calculated.
IVUS examination was performed using 30 MHz catheters
(3.5F Sonicath or 2.9 to 3.2F CVIS, Boston Scientific Corp). The
transducer was advanced distal to the target segment and then withdrawn
manually or mechanically. A second pullback was then performed, and
contrast was injected through the guiding catheter at the most relevant
sites to improve lumen delineation. The complete study was recorded
on 0.5-in Super VHS videotape for off-line analysis. Images of
the MLA within the stent were digitized for measurement. Proximal and
distal (only distal for ostial lesions) reference segments, within
10 mm of the stent borders, were also digitized. Care was taken to
choose sites with the least disease within the reference segment. Lumen
area was defined as the area within the leading edge of intimal and/or
stent struts echoes. Analysis of IVUS recordings was
performed without knowledge of the QCA results.
Balloon nominal CSA was derived from the nominal diameter
provided by the manufacturer. In vivo balloon subexpansion was
calculated as maximal minus minimal QCA-measured balloon CSA.
IVUS-derived elastic recoil was calculated as balloon minimal CSA minus
IVUS MLA, whereas QCA-derived elastic recoil was computed as balloon
minimal diameter minus MLD after stenting.14
Relative (%) values of subexpansion and recoil were obtained with
absolute values normalized by the first term of their subtraction
definition. Acute luminal gain was calculated as final MLA (derived
from IVUS) minus minimal lumen CSA at baseline (derived from QCA).
Maximal achievable gain was calculated as maximal measured balloon size
in vivo minus minimal lumen CSA at baseline. Stent expansion was
defined as the ratio between MLA within the stent and the average lumen
CSA of proximal and distal references. Stent symmetry was defined as
major/minor lumen diameters within the stent (measured by IVUS).
Results are expressed as median±interquartile amplitude.
Reproducibility and agreement were analyzed by Bland-Altman
analysis15 and intraclass correlation
coefficients
(Rintraclass).16
Univariate analyses were performed with Spearman's
correlation coefficient and paired t tests. Variable
selection for the multiple linear regression models of balloon
subexpansion and elastic recoil was performed by use of forward
stepwise selection among the most relevant procedural and angiographic
variables. The additive value of IVUS morphometric variables on
these initial models was then screened by use of a global "chunk
test" in the sample of 35 lesions with baseline IVUS examination; if
this global test was significant, a second stepwise regression
procedure was performed to select most relevant IVUS variables
related to the effect. A 2-tailed P value <0.05 was
considered significant.
Agreement between IVUS and QCA in the assessment of MLA within
the stent was -0.04±1.8 mm2 (Wiktor,
-0.20±1.72 mm2; Palmaz-Schatz,
0.11±1.96 mm2; P=0.5).
Rintraclass values also demonstrated poor
agreement (0.42) between techniques (Wiktor, 0.36; Palmaz-Schatz,
0.48).
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
Procedural Results
Procedural, angiographic, and IVUS data at baseline and after
stenting are shown in Table 1
. No subacute
occlusions occurred in the first 2 weeks after the procedure.
View this table:
[in a new window]
Table 1. Angiographic, IVUS, and Procedural Data at Baseline
and After Stenting
(n=57)
).

View larger version (31K):
[in a new window]
Figure 1. Cumulative distribution functions of MLA at
baseline (Pre MLA) and after stenting (Post MLA) and of balloon minimal
and maximal CSAs. Top arrow indicates maximal achievable acute lumen
gain according to size of balloon selected. However, due to balloon
subexpansion (S) and elastic recoil (R), final achieved acute luminal
gain (bottom arrow) is only 55% of maximal theoretical value.
Measurements of the reference segment and balloon size are shown
in Figure 2
. Although in vivo measured
mean balloon CSA was similar to nominal size, the size of the balloon
was not uniform on its entire length. The balloon maximal CSA was
substantially larger than its minimal CSA (12.5±3.2 versus
8.1±2.3 mm2; P<0.0001);
therefore, values of absolute and relative balloon subexpansion were
4.0±1.8 mm2 (Wiktor, 4.4±1.8;
Palmaz-Schatz, 3.5±1.7 mm2;
P=0.1) and 33±12% (Wiktor, 34±10%; Palmaz-Schatz,
31±11%; P=0.4), respectively. Compared with nominal
balloon size, minimal balloon CSA was 12% smaller (mean difference,
1.1 mm2; 95% CI, 0.7 to 1.4
mm2; P<0.001) and maximal CSA was
30% larger (mean difference, 3.1 mm2; 95%
CI, 2.5 to 3.6 mm2; P<0.001),
yielding a B/A ratio of 1.30±0.3 at the sites of maximal balloon
CSA.

View larger version (30K):
[in a new window]
Figure 2. Reference lumen and balloon dimensions.
Interpolated angiographic vessel reference is in between the proximal
and distal references obtained by IVUS. Balloon nominal CSA was not
different from mean size measured by QCA. However, maximal and minimal
values significantly differed from this nominal size, demonstrating
supranominal balloon stretching at some regions of the treated segment
and balloon subexpansion at others. *P<0.0001.
As shown in Table 2
, the final lumen within the
stent was smaller than the minimum balloon size (P<0.0001
both for QCA-derived diameter and IVUS-derived CSA differences); thus,
values of acute recoil were 0.4±0.5 mm (12±16%) and
1.6±2.3 mm2 (20±25%) as assessed by
QCA-MLD and IVUS-MLA, respectively.
View this table:
[in a new window]
Table 2. Values of Final Lumen Dimensions After Stenting and
Absolute and Relative Values of Acute Elastic Recoil as Assessed by QCA
and IVUS
Increased absolute balloon subexpansion and absolute elastic
recoil were found in Wiktor stents in multiple regression
analysis (Table 3
). As shown,
peak balloon pressure directly correlated with balloon subexpansion,
whereas elastic recoil was higher in de novo than in restenotic
lesions. Baseline IVUS variables added no predictive value in the
assessment of balloon subexpansion, whereas preintervention MLA
inversely correlated with elastic recoil. When the
multivariate models were rerun to assess factors
related to relative values of subexpansion and recoil, the association
between stent type and balloon subexpansion became nonsignificant
(ß=-0.2, P=0.2); predictors of elastic recoil remained
unchanged (stent type, ß=-0.2, P=0.06; type of lesion,
ß=-0.3, P=0.03).
View this table:
[in a new window]
Table 3. Univariate and Multivariate Predictors of Balloon
Subexpansion and Elastic Recoil
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References
It is generally believed that supranominal inflation pressures
should completely expand an angioplasty balloon catheter and that hoop
resistance of stents should virtually avoid the vessel elastic recoil
that follows balloon deflation.17 18 Accordingly,
final vessel lumen size after stenting should closely match the size of
the balloon used for deployment. However, the present study shows
that lumen size after stenting reaches only 74% of the balloon nominal
size and 57% of its inflated maximal in vivo size. The 10%
angiographic residual diameter stenosis noted in the
present study is lower than in previously reported randomized
trials19 20 and is consistent with
previous studies that used high-pressure inflations for stent
deployment.1 Despite the routine use of slightly
oversized balloons and high inflation pressures, balloon subexpansion
and elastic recoil do occur and constitute 2 major sources of residual
stenosis. The identification of these 2 mechanisms may help to
develop strategies to improve stent deployment and, consequently,
long-term results.
The dimensions of an inflated balloon in vivo, which have been
extensively studied for standard balloon angioplasty, represent
a complex interaction of balloon diameter, balloon material, inflation
pressure, and vessel compliance.21 22 Of these
factors, size selection seems crucial because randomized
trials23 have demonstrated that procedural
complications may increase when B/A ratios >1.1 are used. Similarly,
several cases of coronary perforation during high-pressure
stent implantation have been reported due to oversized
balloons.1 18 24 Our study demonstrates that even
adequately sized balloons achieve supranominal dimensions at certain
points during high-pressure stent implantation, leading to potentially
hazardous vessel stretch of the artery. It also demonstrates that
supranominal pressures are frequently not enough to offset the high
vessel impedance of the diseased artery.
Acute elastic recoil designates the immediate reduction in
vessel lumen that occurs after balloon
deflation14 and accounts for a 50% loss in acute
lumen gain during standard balloon
angioplasty.26 27 The present study
demonstrates that stents do not abolish recoil, because 20% of CSA was
lost as a result of this phenomenon. This result is in agreement with
recent observations in studies that used IVUS to assess final lumen
CSA28 and with preliminary results from studies
using an IVUS imaging wire.29 Angiographically
measured recoil was 12%, which is consistent with previously
reported values for Wiktor30 31 32 and
Palmaz-Schatz stents.17 20 32 33 34
The overall reproducibility of QCA measurements of balloon
minimal diameter was ±0.19 mm, slightly
above the repeatability of QCA determination of lumen
diameter.43 Furthermore, the calculation of
balloon CSA from diameters implies the assumption of a circular shape
of balloon cross sections. Although these are potential sources of
error, derivation of balloon CSA from QCA diameters has been validated
by densitometric analyses,14 even when
highly radiopaque stents were attached to the inflated
balloon.44 Future studies using smaller IVUS
devices that are capable of imaging the artery through the inflated
balloon should, however, improve in vivo measurements of expanded
balloons.29 45
Serial IVUS studies have demonstrated that stent
restenosis is related to neointimal hyperplasia
because chronic vessel remodeling is
negligible.46 Until adjuvant therapies aimed at
reducing hyperplasia prove to be efficacious, obtaining the lowest
residual lumen stenosis is the only available method to reduce
restenosis of intracoronary stents and improve
long-term outcome.3 5 The present study
identifies that despite high-pressure deployment, only 55% of
achievable acute lumen gain is finally obtained. Assessment of vessel
size by IVUS examinations improves balloon-vessel matching and may help
to reduce residual lumen stenosis after stenting, as
demonstrated in standard PTCA procedures.47
Baseline IVUS examination may also enable identification of plaque
characteristics related to subexpansion and
recoil48 and hence, definition of tailored
deployment techniques. Debulking before stenting modifies vessel
impedance and seems to be another tempting strategy to increase luminal
gain.48 49 50 Finally, the observation of an
important loss of acute luminal gain due to immediate elastic recoil
emphasizes the need for further research on stent design to maximize
hoop strength and minimize tissue prolapse.
![]()
Selected Abbreviations and Acronyms
B/A
=
balloon/artery
CSA
=
cross-sectional area
IVUS
=
intravascular ultrasound
MLA
=
minimal lumen cross-sectional area
MLD
=
minimal lumen diameter
QCA
=
quantitative coronary angiography
![]()
Acknowledgments
We would like to thank the nurses and technicians of the
catheterization lab and especially the excellent work
of Alicia Barrio at the QCA laboratory. We are also indebted to
Leonardo Fernández Troyano, MEng, PhD, for his assistance in the
review of stent mechanical properties.
![]()
Footnotes
Presented in part at the 69th Scientific Sessions of the American Heart Association, New Orleans, La, November 1013, 1996, and at the XVIIIth Congress of the European Society of Cardiology, Birmingham, United Kingdom, August 1996, and published in abstract form (Circulation. 1997;96[suppl I]I-223).
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
References
1.
Colombo A, Hall P, Nakamura S, Almagor Y, Maiello
L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary
stenting without anticoagulation accomplished with intravascular
ultrasound guidance. Circulation. 1995;91:16761688.
This article has been cited by other articles:
![]() |
H. Samady, M. McDaniel, E. Veledar, B. De Bruyne, N. H. Pijls, W. F. Fearon, and V. Vaccarino Baseline Fractional Flow Reserve and Stent Diameter Predict Optimal Post-Stent Fractional Flow Reserve and Major Adverse Cardiac Events After Bare-Metal Stent Deployment J. Am. Coll. Cardiol. Intv., April 1, 2009; 2(4): 357 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo Drug-eluting stenting the case for post-dilation. J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 22 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. De Benedetti and P. Urban Coronary stenting: why size matters Heart, December 1, 2007; 93(12): 1500 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aziz, J. L Morris, R. A Perry, and R. H Stables Stent expansion: a combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size Heart, December 1, 2007; 93(12): 1562 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Alfonso, A Suarez, D J Angiolillo, M Sabate, J Escaned, R Moreno, R Hernandez, C Banuelos, and C Macaya Findings of intravascular ultrasound during acute stent thrombosis Heart, December 1, 2004; 90(12): 1455 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Spanos, G. Stankovic, J. Tobis, and A. Colombo The challenge of in-stent restenosis: insights from intravascular ultrasound Eur. Heart J., January 2, 2003; 24(2): 138 - 150. [Full Text] [PDF] |
||||
![]() |
N. H.J. Pijls, V. Klauss, U. Siebert, E. Powers, K. Takazawa, W. F. Fearon, J. Escaned, Y. Tsurumi, T. Akasaka, H. Samady, et al. Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up: A Multicenter Registry Circulation, June 25, 2002; 105(25): 2950 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takano, L. A. Yeatman, J. R. Higgins, J. W. Currier, E. Ascencio, K. A. Kopelson, and J. M. Tobis Optimizing stent expansion with new stent delivery systems J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1622 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. de Feyter, P. Kay, C. Disco, and P. W. Serruys Reference Chart Derived From Post-Stent-Implantation Intravascular Ultrasound Predictors of 6-Month Expected Restenosis on Quantitative Coronary Angiography Circulation, October 26, 1999; 100(17): 1777 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dirschinger, A. Kastrati, F.-J. Neumann, P. Boekstegers, S. Elezi, J. Mehilli, H. Schuhlen, J. Pache, E. Alt, R. Blasini, et al. Influence of Balloon Pressure During Stent Placement in Native Coronary Arteries on Early and Late Angiographic and Clinical Outcome : A Randomized Evaluation of High-Pressure Inflation Circulation, August 31, 1999; 100(9): 918 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Carrozza Jr, S. E. Hosley, D. J. C. MD, and D. S. Baim In Vivo Assessment of Stent Expansion and Recoil in Normal Porcine Coronary Arteries : Differential Outcome by Stent Design Circulation, August 17, 1999; 100(7): 756 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Peterson, P. A. Cowper, E. R. DeLong, J. P. Zidar, R. S. Stack, and D. B. Mark Acute and long-term cost implications of coronary stenting J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1610 - 1618. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |